Dr Andree Bates public
[search 0]
More
Download the App!
show episodes
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
Loading …
show series
 
In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as …
  continue reading
 
In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in me…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Tristan Salomon, Founder and CEO of Axom, a company specialising in advanced AI solutions for the pharmaceutical industry. Tristan Salomon has a rich background in developing and implementing AI technologies to enhance manufacturing processes. His expertise lies in creating innovative solutions that imp…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Johannes Kraus, Co-Founder of YOUTH HealthTech. As a former physical therapist Johannes experienced patients suffering and approaching him every day, barely able to treat their diseases without the ability to properly follow their prevention. He founded YOUTH to prevent diseases by focusing on early det…
  continue reading
 
Today Dr Andree Bates chats with Dr Giulio Rognini, Head of Partnerships at Metaphysiks, about how Metaphysiks is revolutionising the world of haptic feedback. Metaphysiks is leading the charge in blending human sensation with the digital realm through their innovative neuro-haptic technology. They’ve even developed the world’s first proprietary ne…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Abishek Jha, Co-Founder and CEO of Elucidata, which cleans and links biomedical data at scale. They advocate for a data-centric approach to AI, arguing that clean data is more valuable than copious data. In this episode, you will learn: How Elucidata’s sources and processes data…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eric Doherty, who has worked in the pharmaceutical industry for 33 years and also in healthcare data AI for 4 years. He is the Former President of PERSOWN, Inc., a medical device company that is developing the next generation of instant Point-of-Care (POC) diagnostic testing, us…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research. Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications. In th…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema. Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the ben…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and…
  continue reading
 
Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation. MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee …
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved s…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales. Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk ab…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition. Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific …
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance, Risk and Compliance at a leading engineering and plant construction company. In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by i…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St.Louis. Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineerin…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adap…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses. Compose Health is an AI platform that giv…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics. Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automati…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas. They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including informat…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI. You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authen…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry. Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and id…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience. SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare pr…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers. They talk about how generative AI is revolutionising digital marketing and …
  continue reading
 
In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm. He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insigh…
  continue reading
 
In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfei…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu. They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic …
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Piet Buyck, CEO and founder of Garvis AI. He talks about how the company's AI system provides significantly more accurate demand forecasting for pharmaceutical companies. Piet explains that Garvis AI leverages different data sources and AI techniques to separately forecast demand …
  continue reading
 
Dr. Andree Bates interviewed Alexander De Ridder, co-founder and CTO of SmythOS, to discuss how their AI agent platform can help pharmaceutical companies scale up their businesses. Alexander explained that SmythOS allows users to orchestrate intelligent agents that can automate workflows, analyse complex datasets, and augment human work. The agents…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Saikiran Chandha, founder of SciSpace. Saikiran discusses how SciSpace uses AI to help researchers save time on literature reviews and writing. SciSpace has developed tools using large language models to summarise papers, generate citations, and paraphrase text while maintaining …
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates talks about the state of AI in biopharma, with a specific focus on how it is being applied across the value chain from research and development to business development, licensing, and clinical trials. She discusses how AI can help accelerate drug discovery by analysing vast amounts of data, g…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates interviews Alice Yu and Mena Abdelsayed, co-founders of OncoCardia. They discuss how their company uses artificial intelligence and stem cell technology to redesign drugs to be safer and more effective. They aim to reduce the time it takes to develop new drugs from almost a decade to just day…
  continue reading
 
In this episode of AI For Pharma Growth Dr Andree Bates is joined by Mark Benthin, Founder, CEO and Executive Chairman of ViiHealth to discuss how AI can be used to quickly engage HCPs and patients through personalising interactions with marketing content. Mark discusses ViiHealth's use of generative AI to create personalised videos for physicians …
  continue reading
 
In this episode of AI For Pharma Growth, host Dr. Andree Bates is joined by guest Dylan Reid, a Legislative Associate focused on health policy. Dylan discusses the current state of AI healthcare policy across various US government organisations. He outlines the FDA approval process, initiatives and committees aimed at balancing innovation and overs…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Mike Kalfus from Graphene AI. Mike discusses his background in data-driven marketing and how he came to work at Graphene AI. He explains how Graphene AI uses natural language processing and machine learning to analyse conversations from a variety of data sources to provide pharma…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Phil Gooch, Founder of Scholarcy. They discuss how pharma can use AI to create accurate summaries of scientific documents to help medical professionals save time when reviewing literature. Phil describes how he developed the idea for Scholarcy after struggling himself with review…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jennifer Bittinger, President of Narrativa. They discuss Narrativa's use of artificial intelligence to automate the writing of clinical study reports and safety reports. Jennifer explains how she joined the company to help expand their AI automation capabilities in North America.…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Max Dordevic, Co-Founder & CEO at NeuroX1. NeuroX1 is a company that utilises AI to identify and treat neurological diseases that affect millions of people every year. Max discusses how NeuroX1 brings their novel approach to the industry by working diligently to bring viable drug…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Richard Graves, Chief Commercial Officer & Co-founder at Sorcero, to discuss how AI can be used to generate strategic literature reviews accurately and reduce costs for medical affairs teams. Richard discusses his background in data science and climate science and how his father'…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Maddie Bell co-founder & CEO, Scheduler.AI. Scheduler.AI's AI-powered virtual assistant helps schedule meetings effortlessly. Maddie discusses the background of starting Scheduling.AI, how long it took to develop the first version, challenges faced with cultural biases, and futur…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Adam Kingl to discuss the future of leadership and innovation in pharma. While new technologies are creating medical breakthroughs, they also threaten major revenue decreases for pharma companies. Adam shares how assessing assumptions around customers, offerings, and how value is…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jack Bowen, Founder of CoLoop about how to use artificial intelligence to speed up research and analysis for the pharmaceutical industry. Jack details how CoLoop addresses the problem of time-consuming qualitative data analysis. He explains how CoLoop analyses transcripts and inte…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Sidi Lemine, Founder & CEO of Jade Kite, to discuss how AI can be leveraged to analyse qualitative market research more efficiently. He shares how Jade Kite uses techniques like text analysis and emotion recognition to reduce timelines for qualitative projects from months to just…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Somer Baburek, CEO & Co-Founder of Hera Biotech. They discuss how Hera Biotech is developing an artificial intelligence-based diagnostic tool for endometriosis using single-cell analysis of gene expression in endometrial cells. This non-invasive approach could help the millions o…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr. Guido Axmann, a personal longevity physician and Chief Medical Officer for FOLK. They discuss how AI and longevity science are converging to advance personalized healthcare and optimization. Topics covered include the hallmarks of ageing, genetic and lifestyle factors, using …
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Charles Gellman, CEO of HiDO Health to discuss how HiDO is using AI and automated medication dispensing to improve patient adherence and outcomes. Charles discusses how his own medical error experience motivated him to start HiDO and ensure patients get the right medications at t…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Francois Gand, Founder and CEO of NURO. Francois shares his inspiring personal journey that led him to create NURO, a non-invasive brain-computer interface. After experiencing tragedies with his family members' health issues and his own accident, Francois was motivated to develop…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Dr. Florian Wolf, Founder and CEO of Mergeflow. Dr. Wolf shares the evolutionary journey of Mergeflow, highlighting how it transformed from a retrieval system into an AI research assistant. The platform's core functions involve meticulous information gathering, relying on a robu…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Steve Raju, the Founder of License to Quill. Steve has a strong interest in marketing, persuasion, and influence, and speaks about how to effectively utilise GPT text models. He explains the overlaps of technology and marketing and the opportunities for companies to use GPT & La…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Omi Bell to explore women's diversity and its impact on clinical trials, along with the transformative role of AI in addressing related challenges. Omi highlights the concerning gender & racial disparity in the pharmaceutical industry. She shares her inspiring story of building …
  continue reading
 
Loading …

Quick Reference Guide